AAFP CME Bulletin
Important drug safety information about telaprevir for readers of the print version of this CME Bulletin.
After reading this CME Bulletin, you should be able to:
- Evaluate techniques for initiating dialogue with patients to determine their risk of hepatitis C virus (HCV) infection.
- Determine the confounding factors that influence the treatment of patients with hepatitis C.
- Evaluate the value of national/local community resources to improve the treatment of patients with hepatitis C.
After reading the CME Bulletin, login to complete the quiz and evaluation. (Members only).